Glucagon [rDNA origin] for Injection Articles
New Zealand considers listing of NovoMix 30 and NovoSeven RT and amendment for Glucagen Hypokit
2 May 2012
Novo Nordisk debuts GlucaGen HypoKit
18 July 2005
Phase II Levormeloxifene Data Raise Concerns
25 June 1998
BIOPHARMACEUTICALS MARKET GROWING FAST
13 June 1994
ROUND-UP OF 1993'S NEW CHEMICAL ENTITIES
31 January 1994
US BIOTECH PRODUCTS IN R&D (Cont'd from last issue)
4 October 1993
Showing 1-7 of 7 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
